Febuxostat efficiently reduces the progression of chronic kidney disease in asymptomatic hyperuricemia: an interventional study

Febuxostat efficiently reduces the progression of chronic kidney disease in asymptomatic hyperuricemia: an interventional study

Abstract Background Therapeutic approaches for addressing asymptomatic chronic kidney disease (CKD) with renal impairment requires careful consideration, as there is a lack of substantial evidence endorsing specific medications. This study examined the outcomes of administering febuxostat to persons...

Full description

Saved in:
Bibliographic Details
Main Authors: Showkat Azad, Pradip Kumar Dutta, Md Nurul Huda, Mohammad Abdul Kader, Biplob Kumar Barua, Mohammad Shawkat Ali, Maria Mehjabin Akhi, Mishu Rahman, Jannatul Efte Ekra, Md. Sujan Islam, Sadia Afrin, Mohammed Mehadi Hassan Chowdhury, Subodh Kumar Sarkar, Ashekul Islam
Format: Article
Language:English
Published: SpringerOpen 2025-04-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Asymptomatic hyperuricemia
CKD
EGFR
Febuxostat
Serum uric acid
Online Access:https://doi.org/10.1186/s43162-025-00446-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s43162-025-00446-5

Similar Items